Skip to main content
OpenTrials
Completed

NCT Number: NCT03114579

Evaluation of the Measurement of Cardiac Output by the NEXFIN HD Monitor in Peroperative

Continuous perioperative cardiac output (DC) and blood pressure (PA) monitoring contributes to hemodynamic stability and ensures adequate perfusion pressure, resulting in a reduction in morbidity and mortality and length of hospital stay.

The monitors usually used in perioperative are either semi-invasive and difficult for calibration (oesophageal Doppler) or invasive (arterial catheter).

The Nexfin HD allows these two measurements and it is completely non-invasive, remains to validate its use in peroperative.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Output Peroperative

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Amiens Picardie

Amiens, Picardie, 80054, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients candidate for surgery under general anesthesia requiring oesophageal Doppler or arterial catheter hemodynamic monitoring.

Exclusion criteria

  • Patients with cardiac and thoracic surgery,
  • patients for whom access to the head is impossible,
  • facial trauma patients,
  • patients with aortic malformation, dilation or coarctation,
  • patients with aortic dissection,
  • patients with vascular surgery with aortic clamping,
  • patients with a tumor, stenosis or varices of the esophagus,
  • patients with severe oesophagitis,
  • patients with thoracic radiotherapy
  • patients under guardianship or curatorship or deprived of liberty.

Treatment and study plan

Intraoperative heart rate measurement (reference method)

Device

Measurement of cardiac output by both monitors: NEXFIN HD and oesophageal doppler, blood pressure measurement by the catheter and NEXFIN HD monitor, and cardiac output and blood pressure measurements after treatment administration (vasoconstrictor or filling)

NEXFIN HD

Device

Primary outcomes

  1. Overall survival defines as the time between the date of surgery and death or date of last news

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: NEXFIN

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Apr 14, 2017
Registry last updated
Apr 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.